U.S. Plasmid DNA Contract Manufacturing Market Size, Share & Trends Analysis Report By Application, By End-use, By Therapeutic Area, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Application
                        1.2.2. Therapeutic Area
                        1.2.3. End-use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Italy
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Application
                        2.2.2. Therapeutic Area
                        2.2.3. End-use
                    2.3. Competitive Insights
Chapter 3. Plasmid DNA Contract Manufacturing Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                    3.3. Market Driver Analysis
                        3.3.1. Increasing disease prevalence
                        3.3.2. Growing Investments in Research Studies
                        3.3.3. Growing Popularity of Gene Therapy Introduction to technologically advanced healthcare services
                    3.4. Market Restraint Analysis
                        3.4.1. Lack of advanced infrastructure for manufacturing in certain developing countries
                        3.4.2. Quality Issues associated with Contract Manufacturing
                        3.4.3. U.S. Plasmid DNA Contract Manufacturing Market Analysis Tools
                        3.4.4. Industry Analysis - Porter’s Five Forces
                            3.4.4.1. Supplier power
                            3.4.4.2. Buyer power
                            3.4.4.3. Substitution threat
                            3.4.4.4. Threat of new entrant
                            3.4.4.5. Competitive rivalry
                        3.4.5. PESTEL Analysis
                            3.4.5.1. Political landscape
                            3.4.5.2. Technological landscape
                            3.4.5.3. Economic landscape
Chapter 4. U.S. Plasmid DNA Contract Manufacturing Market Application Estimates & Trend Analysis
                    4.1. U.S. Plasmid DNA Contract Manufacturing Market Application Dashboard
                    4.2. U.S. Plasmid DNA Contract Manufacturing Market Application Movement Analysis
                    4.3. U.S. Plasmid DNA Contract Manufacturing Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Plasmid DNA contract manufacturing (EHR) Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.1. Gene Therapy
                            4.4.1.1. Gene Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.2. Immunotherapy
                            4.4.2.1. Immunotherapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
                        4.4.3. Others
                            4.4.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. U.S. Pharmaceutical Market: Therapeutic Area Estimates & Trend Analysis
                    5.1. U.S. Plasmid DNA contract manufacturing Market Therapeutic Area Dashboard
                    5.2. U.S. Plasmid DNA Contract Manufacturing Market Therapeutic Area Movement Analysis
                    5.3. U.S. Plasmid DNA Contract Manufacturing Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Cancer
                        5.4.1. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.5. Infectious Disease
                        5.5.1. Infectious Disease Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.6. Autoimmune Diseases
                        5.6.1. Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.7. Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        5.7.1. Cardiovascular Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.8. Others
                        5.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Pharmaceutical Market: End-use Outlook Estimates & Trend Analysis
                    6.1. U.S. Plasmid DNA contract manufacturing End-use Model Dashboard
                    6.2. U.S. Plasmid DNA Contract Manufacturing Market End-use Movement Analysis
                    6.3. Pharmaceutical Market: Business Model Outlook Movement Analysis
                        6.3.1. Pharmaceutical and Biotechnology Companies
                        6.3.2. Pharmaceutical and Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.3. Research Institutes
                        6.3.4. Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. Cerner Corporation
                        7.3.5. Aldevron
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Charles River Laboratories
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Akron Biotech
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. VGXI, Inc
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Catalent, Inc
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. DH Life Sciences, LLC
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Recipharm AB
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. TriLink BioTechnologies
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. AGC BiologicsL
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives
                        7.3.14. Thermo Fisher
                            7.3.14.1. Company overview
                            7.3.14.2. Financial performance
                            7.3.14.3. Product benchmarking
                            7.3.14.4. Strategic initiatives
                        7.3.15. Scientific Inc.
                            7.3.15.1. Company overview
                            7.3.15.2. Financial performance
                            7.3.15.3. Product benchmarking
                            7.3.15.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Pharmaceutical Market, By Application, 2018 - 2030 (USD Billion)
Table 3. U.S. Pharmaceutical Market, By Therapeutic Area, 2018 - 2030 (USD Billion)
Table 4. U.S. Pharmaceutical Market, By End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Plasmid DNA Contract Manufacturing Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Plasmid DNA contract manufacturing Market: Application outlook and key takeaways
Fig. 15 Plasmid DNA contract Manufacturing Market: Application Movement Analysis & market share 2023 & 2030
Fig. 16 Gene therapy market, 2018 - 2030 (USD Billion)
Fig. 17 Immunotherapy market, 2018 - 2030 (USD Billion)
Fig. 18 Others
Fig. 19 Plasmid DNA contract manufacturing Market Therapeutic area outlook and key takeaways
Fig. 20 Plasmid DNA contract manufacturing Market: Therapeutic area movement analysis & market share 2023 & 2030
Fig. 21 Cancer market, 2018 - 2030 (USD Billion)
Fig. 22 Infectious diseases market, 2018 - 2030 (USD Billion)
Fig. 23 Autoimmune diseases market, 2018 - 2030 (USD Billion)
Fig. 24 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
Fig. 25 Others market, 2018 - 2030 (USD Billion)
Fig. 26 Plasmid DNA Contract Manufacturing Market:
Fig. 27 Plasmid DNA contract manufacturing Market: End-use outlook and key takeaways
Fig. 28 Plasmid DNA contract Manufacturing Market: End-use Movement Analysis & market share 2023 & 2030
Fig. 29 Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Billion)
Fig. 30 Research Institute market, 2018 - 2030 (USD Billion)